Recombinant Rabbit Prolactin Receptor (PRLR) is a synthetic, non-glycosylated protein engineered to mimic the extracellular domain (ECD) of the native rabbit prolactin receptor. It belongs to the class I cytokine receptor family and plays a critical role in mediating prolactin (PRL)-induced signaling pathways, including JAK2-STAT5, PI3K/Akt, and MAPK cascades . This recombinant form is produced in Escherichia coli and is widely used in research to study PRLR-ligand interactions, signaling mechanisms, and therapeutic applications .
Recombinant rabbit PRLR is produced via bacterial expression systems, followed by purification using methods like nickel-affinity chromatography (for His-tagged variants) or proprietary chromatographic techniques .
Recombinant rabbit PRLR-ECD is functionally validated through:
Ligand Binding: Forms a 1:1 complex with rabbit prolactin (rbPRL) and other lactogenic hormones (e.g., ovine PRL) .
Biological Assays:
| Assay | Outcome | Source |
|---|---|---|
| Nb2 Cell Proliferation | Inhibition of PRL-induced growth (EC₅₀ ~1–10 nM) | |
| Binding Affinity | High-affinity interaction with rbPRL (Kd ~10⁻⁹ M) |
Recombinant rabbit PRLR differs from human and rodent receptors in its binding kinetics and signaling efficiency. For example:
Species-Specific Activity: Rabbit PRL exhibits 4–8-fold lower activity compared to human PRL in Nb2 and Baf3 cell assays .
Domain Variability: The cytoplasmic domain length (absent in recombinant ECD) modulates ligand binding and signal transduction in native receptors .
Signaling Pathways: Recombinant PRLR is used to dissect PRL-induced JAK2-STAT5 activation in breast cancer cells .
Receptor Dimerization: The ECD’s D1 and D2 subdomains are critical for PRL-induced receptor dimerization and signaling .
Cancer Research: Overexpression of PRLR in breast cancer correlates with tumor progression, making it a potential therapeutic target .
Reproductive Biology: PRLR-ECD inhibits PRL signaling in ovarian granulosa cells, influencing follicular development .
| Parameter | Recombinant PRLR | Native PRLR |
|---|---|---|
| Glycosylation | Absent | Present (cell surface) |
| Solubility | High (ECD-focused) | Membrane-bound |
| Signaling Efficiency | Partial (ECD-only) | Full (ICD-dependent) |
Functional Limitations: The absence of the intracellular domain restricts full signal transduction studies .
Species Variability: Cross-reactivity with non-rabbit PRLR antibodies (e.g., human-specific clones) is limited .
Storage Handling: Lyophilized PRLR requires strict storage at -18°C to prevent oligomerization .
This protein is a receptor for prolactin, a hormone produced by the anterior pituitary gland.
Rabbit PRLR is a membrane protein primarily involved in mammary gland development and lactation. The full-length recombinant rabbit PRLR has a molecular mass of approximately 94 kDa, which corresponds to the translation product of the entire cDNA coding region. Interestingly, the receptor biochemically identified in the rabbit mammary gland is much shorter, suggesting that the receptor undergoes post-translational modifications in vivo .
Several recombinant forms of rabbit PRLR can be produced:
Full-length receptor forms (L1, L2): Associated with the membrane fraction
Truncated membrane form (S): Retains membrane association
Secretable form of the extracellular domain (E): Predominantly secreted into medium
Intracellular domain forms (I1, I2): Expressed as soluble proteins, with a significant portion accumulating in culture medium
Rabbit prolactin exhibits lower binding affinity to its homologous receptor compared to other species' PRLs (such as ovine PRL). This difference is attributed to its faster and more complete dissociation kinetics . The binding potency of recombinant rbPRL to its receptor varies based on where the receptor is expressed:
| Receptor Expression System | Relative Binding Potency |
|---|---|
| Endogenous (mammary gland) | One log unit lower than with other species |
| Recombinant in mammalian cells | One log unit lower than with other species |
| Recombinant in insect cells | Higher affinity than above systems |
This variation in binding potency is likely related to cell-dependent receptor densities .
Verification of proper folding and functionality of recombinant rabbit PRLR can be assessed through multiple complementary approaches:
Circular dichroism (CD) spectroscopy: Comparing spectral characteristics with native PRLR
Binding parameter analysis: Assessing affinity constants and binding kinetics
Bioactivity assays: Measuring functional responses such as:
These methodologies ensure that the recombinant receptor maintains native conformation and biological functionality.
Several expression systems have been successfully employed for rabbit PRLR production, each with distinct advantages:
For functional studies, the insect/baculovirus expression system has proven particularly effective for producing multiple recombinant forms of rabbit PRLR in large quantities while maintaining their ligand-binding capabilities .
Optimal purification strategies depend on the expression system and specific form of PRLR:
For tagged PRLR constructs:
For untagged or native-like PRLR:
Sequential chromatography techniques:
a. Ion-exchange chromatography
b. Size exclusion chromatography
c. Affinity chromatography using ligand (PRL) as bait
Quality assessment criteria:
Recombinant rabbit PRLR provides an excellent model for investigating receptor dimerization and activation mechanisms through several advanced techniques:
FRET (Fluorescence Resonance Energy Transfer):
BRET (Bioluminescence Resonance Energy Transfer):
Co-immunoprecipitation assays:
Native electrophoresis:
These methodologies have revealed that the hormone binding site is located in the extracellular domain, which can function autonomously as a PRL-binding soluble protein .
Understanding the differences between recombinant and native forms is crucial for experimental interpretation:
Post-translational modifications:
Conformation and ligand binding:
Functional consequences:
The experimental context significantly influences PRLR signaling outcomes:
Cell type-dependent effects:
Receptor form-dependent signaling:
Ligand-specific responses:
These variations highlight the importance of carefully designing experiments and selecting appropriate models when studying PRLR function.
When encountering expression or folding challenges with recombinant rabbit PRLR:
Expression optimization:
Adjust induction conditions (temperature, time, inducer concentration)
Optimize codon usage for the expression system
Co-express chaperones to assist with folding
Use fusion tags that enhance solubility (e.g., SUMO, thioredoxin)
Refolding techniques for inclusion bodies:
Quality control assessment:
Measuring binding kinetics requires precise methodologies:
Surface Plasmon Resonance (SPR):
Immobilize receptor or ligand on sensor chip
Measure real-time association and dissociation rates
Calculate binding constants (Ka, Kd, KD)
Radioligand binding assays:
Use iodinated prolactin with consistent specific activity
Perform saturation binding to determine Bmax and KD
Conduct competition binding with unlabeled ligands
Analyze association/dissociation kinetics
Fluorescence-based methods:
Bioactivity correlation:
Selection of appropriate cellular models is critical for studying rabbit PRLR:
Established cell lines:
Generation of stable expressing cell lines:
Co-transfect PRLR constructs with antibiotic resistance genes (e.g., pcDNA3.1 with geneticin resistance)
Use optimal DNA ratios (10:1 recommended)
Select with appropriate antibiotic concentration (e.g., 500 μg/mL Geneticin)
Characterize clones for PRLR expression and PRL-responsiveness
Create different expression level clones (e.g., "PRLR high" or "PRLR low")
Primary cell models:
Functional validation:
Recombinant rabbit PRLR provides valuable insights into protein trafficking:
Vesicular transport studies:
Experimental approaches:
Live-cell imaging with fluorescently tagged constructs
Co-localization with vesicle markers
Pulse-chase experiments to track protein movement
Utilization of trafficking inhibitors to identify specific pathways
Physiological relevance:
Understanding species differences requires comparative approaches:
Binding affinity variations:
Experimental design for comparative studies:
Express receptors from different species in the same cellular background
Use chimeric receptors to identify domains responsible for species differences
Compare binding kinetics (association/dissociation rates) across species
Correlate binding with downstream signaling activation
Functional consequences:
Advanced structural techniques offer deeper insights:
X-ray crystallography:
Determine atomic resolution structures of:
Rabbit PRLR extracellular domain
PRLR-PRL complexes
Full-length receptor (challenging but valuable)
Cryo-electron microscopy:
Visualize membrane-embedded receptor
Capture different conformational states
Study larger complexes with signaling partners
Nuclear Magnetic Resonance (NMR):
Analyze dynamic properties and conformational changes
Study smaller domains or extracellular fragments
Investigate ligand-receptor interactions in solution
Computational approaches:
Molecular dynamics simulations to study:
Conformational flexibility
Binding mechanisms
Dimerization processes
Homology modeling based on related receptors
Structure-based drug design for receptor modulators
These structural approaches would help explain the observed differences in binding affinity and signaling between rabbit PRLR and other species, potentially revealing unique structural features that influence its function.